Antine E. Stenbit
YOU?
Author Swipe
View article: Efficacy of Therapeutic Plasma Exchange Alone or in Combination with Ruxolitinib for the Treatment of Penn Class 3 and 4 Cytokine Release Syndrome Complicating COVID-19
Efficacy of Therapeutic Plasma Exchange Alone or in Combination with Ruxolitinib for the Treatment of Penn Class 3 and 4 Cytokine Release Syndrome Complicating COVID-19 Open
This study was conducted to validate the efficacy of therapeutic plasma exchange (TPE) in reducing the excessive cytokine load complicating a subset of patients with severe COVID-19 and respiratory compromise. Additionally, this trial expl…
View article: Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19
Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19 Open
ClinicalTrials.gov NCT04374149.
View article: Improvement of Chest Wall Compliance Immediately Following Subcutaneous Placement of Central Venous Catheter for Decompression of Massive Subcutaneous Emphysema
Improvement of Chest Wall Compliance Immediately Following Subcutaneous Placement of Central Venous Catheter for Decompression of Massive Subcutaneous Emphysema Open